These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26418325)

  • 1. Pathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na(+)/K(+)-ATPase.
    Stindl J; Tauber P; Sterner C; Tegtmeier I; Warth R; Bandulik S
    Endocrinology; 2015 Dec; 156(12):4582-91. PubMed ID: 26418325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3.
    Tauber P; Aichinger B; Christ C; Stindl J; Rhayem Y; Beuschlein F; Warth R; Bandulik S
    Endocrinology; 2016 Jun; 157(6):2489-99. PubMed ID: 27035656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
    Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the effect of hyperaldosteronism-inducing mutations in Na/K pumps.
    Meyer DJ; Gatto C; Artigas P
    J Gen Physiol; 2017 Nov; 149(11):1009-1028. PubMed ID: 29030398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.
    Beuschlein F; Boulkroun S; Osswald A; Wieland T; Nielsen HN; Lichtenauer UD; Penton D; Schack VR; Amar L; Fischer E; Walther A; Tauber P; Schwarzmayr T; Diener S; Graf E; Allolio B; Samson-Couterie B; Benecke A; Quinkler M; Fallo F; Plouin PF; Mantero F; Meitinger T; Mulatero P; Jeunemaitre X; Warth R; Vilsen B; Zennaro MC; Strom TM; Reincke M
    Nat Genet; 2013 Apr; 45(4):440-4, 444e1-2. PubMed ID: 23416519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel genes in primary aldosteronism.
    Fischer E; Beuschlein F
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):154-8. PubMed ID: 24739312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
    Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro.
    Williams TA; Monticone S; Morello F; Liew CC; Mengozzi G; Pilon C; Asioli S; Sapino A; Veglio F; Mulatero P
    Hypertension; 2010 Jun; 55(6):1468-75. PubMed ID: 20385969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
    Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
    Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kobuke K; Oki K; Gomez-Sanchez CE; Gomez-Sanchez EP; Itcho K; Ohno H; Nagano G; Yoshii Y; Baba R; Kodama T; Arihiro K; Hattori N; Yoneda M
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
    Tauber P; Penton D; Stindl J; Humberg E; Tegtmeier I; Sterner C; Beuschlein F; Reincke M; Barhanin J; Bandulik S; Warth R
    Endocrinology; 2014 Apr; 155(4):1353-62. PubMed ID: 24506072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism.
    Lenzini L; Caroccia B; Campos AG; Fassina A; Belloni AS; Seccia TM; Kuppusamy M; Ferraro S; Skander G; Bader M; Rainey WE; Rossi GP
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E674-82. PubMed ID: 24285684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
    Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.
    Velázquez-Fernández D; Caramuta S; Özata DM; Lu M; Höög A; Bäckdahl M; Larsson C; Lui WO; Zedenius J
    Eur J Endocrinol; 2014 Apr; 170(4):583-91. PubMed ID: 24446485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas.
    Saner-Amigh K; Mayhew BA; Mantero F; Schiavi F; White PC; Rao CV; Rainey WE
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1136-42. PubMed ID: 16332935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.
    Zheng FF; Zhu LM; Nie AF; Li XY; Lin JR; Zhang K; Chen J; Zhou WL; Shen ZJ; Zhu YC; Wang JG; Zhu DL; Gao PJ
    Hypertension; 2015 Mar; 65(3):622-8. PubMed ID: 25624344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.